BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31736752)

  • 1. Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis.
    Luque-Martin R; Van den Bossche J; Furze RC; Neele AE; van der Velden S; Gijbels MJJ; van Roomen CPPA; Bernard SG; de Jonge WJ; Rioja I; Prinjha RK; Lewis HD; Mander PK; de Winther MPJ
    Front Pharmacol; 2019; 10():1242. PubMed ID: 31736752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease.
    Elfiky AMI; Ghiboub M; Li Yim AYF; Hageman IL; Verhoeff J; de Krijger M; van Hamersveld PHP; Welting O; Admiraal I; Rahman S; Garcia-Vallejo JJ; Wildenberg ME; Tomlinson L; Gregory R; Rioja I; Prinjha RK; Furze RC; Lewis HD; Mander PK; Heinsbroek SEM; Bell MJ; de Jonge WJ
    J Crohns Colitis; 2022 May; 16(4):668-681. PubMed ID: 34633041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia.
    Furze RC; Molnar J; Parr NJ; Ahmad F; Henry Y; Howe D; Singh R; Toal M; Bassil AK; Bernard SG; Davis RP; Gibson A; Maller NC; Sharp C; Tough DF; Prinjha RK; Lewis HD
    Br J Clin Pharmacol; 2022 Dec; 88(12):5238-5256. PubMed ID: 35655123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs.
    Needham LA; Davidson AH; Bawden LJ; Belfield A; Bone EA; Brotherton DH; Bryant S; Charlton MH; Clark VL; Davies SJ; Donald A; Day FA; Krige D; Legris V; McDermott J; McGovern Y; Owen J; Patel SR; Pintat S; Testar RJ; Wells GM; Moffat D; Drummond AH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):132-42. PubMed ID: 21778281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenome as a putative target for skin repair: the HDAC inhibitor Trichostatin A modulates myeloid progenitor plasticity and behavior and improves wound healing.
    Cabanel M; da Costa TP; El-Cheikh MC; Carneiro K
    J Transl Med; 2019 Jul; 17(1):247. PubMed ID: 31366356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease.
    Elfiky AMI; Hageman IL; Becker MAJ; Verhoeff J; Li Yim AYF; Joustra VW; Mulders L; Fung I; Rioja I; Prinjha RK; Smithers NN; Furze RC; Mander PK; Bell MJ; Buskens CJ; D'Haens GR; Wildenberg ME; de Jonge WJ
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting epigenetic enzymes to improve atherogenic macrophage functions.
    Van den Bossche J; Neele AE; Hoeksema MA; de Heij F; Boshuizen MC; van der Velden S; de Boer VC; Reedquist KA; de Winther MP
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):396-402. PubMed ID: 25446073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity.
    Cabanel M; Brand C; Oliveira-Nunes MC; Cabral-Piccin MP; Lopes MF; Brito JM; de Oliveira FL; El-Cheikh MC; Carneiro K
    PLoS One; 2015; 10(7):e0132984. PubMed ID: 26196676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of
    Babaev VR; Huang J; Ding L; Zhang Y; May JM; Linton MF
    Front Immunol; 2018; 9():215. PubMed ID: 29487597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis.
    Neele AE; Van den Bossche J; Hoeksema MA; de Winther MP
    Eur J Pharmacol; 2015 Sep; 763(Pt A):79-89. PubMed ID: 26004034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.
    Lombardi MS; Gilliéron C; Dietrich D; Gabay C
    J Leukoc Biol; 2016 May; 99(5):711-21. PubMed ID: 26590148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases.
    Das Gupta K; Shakespear MR; Iyer A; Fairlie DP; Sweet MJ
    Clin Transl Immunology; 2016 Jan; 5(1):e62. PubMed ID: 26900475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma.
    Gunawardhana LP; Gibson PG; Simpson JL; Powell H; Baines KJ
    Clin Exp Allergy; 2014 Jan; 44(1):47-57. PubMed ID: 24355018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases.
    Felice C; Lewis A; Armuzzi A; Lindsay JO; Silver A
    Aliment Pharmacol Ther; 2015 Jan; 41(1):26-38. PubMed ID: 25367825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
    Han SB; Lee JK
    Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation.
    Sun H; Jiang J; Gong L; Li X; Yang Y; Luo Y; Guo Z; Lu R; Li H; Li J; Zhao J; Yang N; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109352. PubMed ID: 31586905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid
    Huo M; Huang Y; Qu D; Zhang H; Wong WT; Chawla A; Huang Y; Tian XY
    FASEB J; 2017 Mar; 31(3):1097-1106. PubMed ID: 27927724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
    Li K; Ching D; Luk FS; Raffai RL
    Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.